This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Sealife Pharma Gmbh. Active years: 2019-2021.
Company Filing History:
Years Active: 2019-2021
Title: Miroslav Genov: Innovator in Polyguanidine Research
Introduction
Miroslav Genov is a notable inventor based in Tulln, Austria. He has made significant contributions to the field of polymer chemistry, particularly in the development of polyguanidine compounds. With a total of 2 patents to his name, Genov's work focuses on innovative methods for treating infections.
Latest Patents
Genov's latest patents include groundbreaking research on polyguanidine polymers and their methods of use. The first patent describes polyguanidines of various formulas that can be utilized to treat infections, including bacterial, viral, or fungal infections. These polyguanidines serve as effective ex vivo microbial agents. The second patent outlines a method for producing polyguanidines through a polycondensation reaction involving guanidine derivatives. This method provides a systematic approach to synthesizing these valuable compounds.
Career Highlights
Miroslav Genov is currently associated with Sealife Pharma GmbH, where he continues to advance his research in polymer chemistry. His work has garnered attention for its potential applications in medical treatments, particularly in combating infections.
Collaborations
Genov collaborates with esteemed colleagues, including Alexander Pretsch and Michael Nagl, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Miroslav Genov's contributions to the field of polyguanidine research highlight his role as a significant inventor. His patents reflect a commitment to developing effective solutions for infection treatment.